Aspirin Inhibits Metastatic Cancer Spread, Reducing Mortality by 21 Percent: Study
Aspirin is a long-established and widely used medication with a rich history. In addition to its well-known uses for pain relief and its anti-inflammatory and anticoagulant properties, a recent study indicates that cancer patients who take low-dose aspirin daily experience a 21 percent reduction in mortality. Furthermore, there is evidence of aspirin’s role in preventing cancer metastasis. Cancer is one of the leading causes of global mortality. In 2020 alone, there were approximately 19.3 million new cancer cases worldwide and nearly 10 million deaths. According to statistics, 1 in 6 reported deaths are attributed to cancer. The most common types of cancer include breast, lung, colorectal, prostate, and stomach. In November 2023, researchers from Cardiff University in the United Kingdom published a comprehensive review in the British Journal of Cancer (BJC) outlining aspirin’s potential to reduce cancer mortality, prevent metastatic cancer spread, and minimize vascular complication...